Metronomic Chemotherapy in Patients With Advanced Solid Tumor With Bone Metastasis and Advanced Pretreated Osteosarcoma

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

September 5, 2016

Study Completion Date

November 16, 2021

Conditions
Solid TumorOsteosarcoma
Interventions
DRUG

Sirolimus combined with CP, MT and ZA

"Cyclophosphamide, Methotrexate and Sirolimus will be administrated orally. Zoledronic Acid will be administrated by infusion (IV).~Trial based on a dose escalating study design assessing two dose levels of sirolimus when prescribed in combination with metronomic cyclophosphamide (CP), methotrexate (MT) and zoledronic acid (ZA) followed by an expansion cohort once the MTD is established."

Trial Locations (3)

33076

Institut Bergonié, Bordeaux

59000

Centre Oscar Lambret, Lille

69008

Centre Léon Bérard, Lyon

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Reliable Cancer Therapies

INDUSTRY

collaborator

Pfizer

INDUSTRY

lead

Institut Bergonié

OTHER